Walmart's new benefits initiative includes covering GLP-1 medications and insulin for employees.
Walmart Inc. recently announced that it will cover GLP-1 medications and insulin at no cost for its employees as part of a new benefits initiative. This decision aims to improve healthcare access for workers, especially those managing diabetes and obesity. Following the announcement, Walmart's stock closed at US$113.32, reflecting a 1.55% increase on the day and a 7.62% rise over the past week.
Advertisement
Walmart Inc.
WMT.US
WMT.US
Walmart Inc.
WealthAwesomeMarket cap
$899.90B
P/E
41.0x
Div. yield
0.87%
Div. / share
$0.96
52W high
$134.84
52W low
$98.05
1W change
+7.62%
Beta
0.58
Analyst Price Targets
Based on 43 analysts covering WMT · as of Oct 5, 2026
Wall Street analysts forecast WMT stock price to rise 12.1% over the next 12 months.
Consensus
Buy4.47 / 5.00
Avg. Target
C$126.78
+12.1% Upside
Current Price
C$113.08
Last close
Analyst Breakdown (43 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WMT's historical volatility
30-Day Vol
21.5%
Annualized
90-Day Vol
27.0%
Annualized
Trend (90d)
-3.3%
Annualized drift
90d Mean
C$111.76
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$112.64 | C$104.58 – C$121.32 |
| 60 trading days | C$112.20 | C$101.01 – C$124.62 |
| 90 trading days | C$111.76 | C$98.27 – C$127.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Walmart's decision to enhance employee benefits may impact its workforce productivity and overall financial health.
Walmart's stock rises 1.55% following benefits announcement.
The stock closed at US$113.32, with a P/E ratio of 40.971, amid lower trading volume compared to its 20-day average.
Bull case
Expanding benefits could boost employee satisfaction and retention, which may lead to higher productivity and reduced turnover costs.
Bear case
However, the increased healthcare costs associated with this initiative could affect profit margins if not managed properly.
What Walmart's Benefits Initiative Entails
Advertisement
Walmart's initiative to cover GLP-1 medications and insulin at no cost for employees marks a significant enhancement to its benefits strategy. This move aims to help employees manage chronic health conditions, particularly diabetes and obesity. While this initiative is likely to increase healthcare costs, it could also have implications for profit margins. Investors will be watching closely to see how these changes affect the company's overall financial performance.
Market Reaction and Stock Performance
Walmart's stock saw a positive response following the benefits announcement, closing up 1.55% at US$113.32. Over the past week, the stock has risen by 7.62%, indicating growing investor confidence. The trading volume for the day was 7,792,484 shares, which is only 0.62 times the 20-day average volume of 22,317,322 shares. The stock is currently trading 4.4% above its 50-day moving average of US$108.54 but is 4.1% below its 200-day moving average of US$118.18.
Future Considerations for Walmart
As Walmart rolls out this benefits initiative, it will be essential to monitor its impact on employee productivity and satisfaction. The company's current position within its 52-week range of US$98.05 to US$134.84 shows that the stock is currently at 42% of its range. Analysts have an average target of US$126.78 for Walmart, suggesting an implied upside of approximately 11.9%. This initiative could influence how employees view their roles and responsibilities within the company, potentially affecting retention and hiring.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
